Related Experiment Video
Updated: Oct 26, 2025
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.8K
COVID-19 ARDS in two patients with left ventricular assist device
Mustafa Mert Özgür1, Hakan Hançer2, Özge Altaş2
1Department of Cardiovascular Surgery, Koşuyolu High Specialization Education and Research Hospital, Istanbul, Turkey. drmertozgur@gmail.com.
Summary
This study presents the first two cases in Turkey of patients with left ventricular assist devices (LVAD) who contracted COVID-19. These patients highlight the challenges in diagnosing COVID-19 symptoms that overlap with heart failure or LVAD issues.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) has caused significant global mortality.
- Chronic diseases are linked to severe COVID-19 outcomes.
- Left ventricular assist device (LVAD) patients may be at increased risk for severe COVID-19.
Observation:
- COVID-19 symptoms like dyspnea and fatigue can mimic heart failure or LVAD dysfunction.
- Accurate diagnosis and treatment are crucial for LVAD patients with potential COVID-19.
Findings:
- This report details the first two cases of COVID-19 in LVAD-supported patients in Turkey.
- The cases underscore diagnostic complexities in this vulnerable population.
Implications:
- Early and careful evaluation is essential for managing COVID-19 in LVAD patients.
- These cases contribute to understanding COVID-19's impact on mechanical circulatory support recipients.
- Further research is needed to guide clinical practice for LVAD patients during pandemics.
More Related Videos
Related Concept Videos
01:29Acute Respiratory Failure-V
247
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
247
01:21Acute Respiratory Failure-II
547
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
547
01:21Acute Respiratory Failure-I
446
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
446
01:30Acute Respiratory Failure-III
417
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
417
01:23Acute Respiratory Failure-IV
292
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
292
01:29Cardiomyopathy V: Interprofessional Care
73
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
73